amiodarone has been researched along with Prosthesis Durability in 2 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spragg, DD | 1 |
| Marine, JE | 1 |
| Vischer, AS | 1 |
| Sticherling, C | 1 |
| Kühne, MS | 1 |
| Osswald, S | 1 |
| Schaer, BA | 1 |
2 other studies available for amiodarone and Prosthesis Durability
| Article | Year |
|---|---|
Inappropriate biventricular implantable cardioverter defibrillator firing due to cryptogenic double counting.
Topics: Amiodarone; Atrial Fibrillation; Defibrillators, Implantable; Heart Block; Humans; Male; Middle Aged | 2010 |
Role of defibrillation threshold testing in the contemporary defibrillator patient population.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Resynchronization Therapy Devices; Cardiomyopathy, | 2013 |